Vimarsana
Biggest News Aggregation in the World

Page 20 - Pathology Lab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pathology Lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pathology Lab Today - Breaking & Trending Today

Sepsis Diagnostics Market worth $771 million by 2026 - Exclusive Report by MarketsandMarkets™ - Vimarsana News

Sepsis Diagnostics Market worth $771 million by 2026 - Exclusive Report by MarketsandMarkets™

/PRNewswire/ -- According to the new market research report "Sepsis Diagnostics Market by Technology (Microbiology, PCR, Sequencing, Biomarkers), Product...

Sepsis Diagnostics Market worth $771 million by 2026 - Exclusive Report by MarketsandMarkets - Vimarsana News

Sepsis Diagnostics Market worth $771 million by 2026 - Exclusive Report by MarketsandMarkets

CHICAGO, Feb. 4, 2022 /PRNewswire/ -- According to the new market research report "Sepsis Diagnostics Market by Technology (Microbiology, PCR, Sequencing, Biomarkers), Product (Reagents, Assay

Investegate |F. Hoffmann-La Roche Ltd Announcements | F. Hoffmann-La Roche Ltd: [Ad hoc announcement pursuant to Art. 53 LR] Roche reports good results in 2021 - Vimarsana News

Investegate |F. Hoffmann-La Roche Ltd Announcements | F. Hoffmann-La Roche Ltd: [Ad hoc announcement pursuant to Art. 53 LR] Roche reports good results in 2021

Investegate announcements from F. Hoffmann-La Roche Ltd, [Ad hoc announcement pursuant to Art. 53 LR] Roche reports good results in 2021

F. Hoffmann-La Roche Ltd: [Ad hoc announcement pursuant to Art. 53 LR] Roche reports good results in 2021 - Vimarsana News

F. Hoffmann-La Roche Ltd: [Ad hoc announcement pursuant to Art. 53 LR] Roche reports good results in 2021

Basel, 3 February 2022 Group sales increase 9%1 at constant exchange rates (CER); 8% in Swiss francsPharmaceuticals Division sales increase 3%; continued strong demand for newly launched medicines

Roche Diagnostics Revenues Grow 29 Percent in 2021 - Vimarsana News

Roche Diagnostics Revenues Grow 29 Percent in 2021

The firm saw growth in all of its diagnostics segments, including point-of-care testing and molecular laboratory testing.